Sedlaczek A M, Serwatowski P, Spiewak W
Kliniki Chorób Płuc i Gruźlicy Pomorskiej Akademii Medycznej w Szczecinie.
Pneumonol Alergol Pol. 1995;63(5-6):293-7.
The results of the treatment 33 patients for smear-positive pulmonary tuberculosis with Isoniazid, Rifampicin, Pyrazinamide and Streptomycin administrated during first two weeks daily, from 3 to 8 week also with these four drugs but in a little higher doses twice weekly and next Isoniazid and Rifampicin during 9-26 weeks also twice weekly as in standard Polish model were described. After therapy with above described regimen all patients became smear-negative and radiological improvement was observed. Drugs in higher doses were well tolerated. Only abnormality in laboratory findings was temporary elevated level of uric acid, which recovered to normal values before the end of therapy. Costs of antituberculous drugs were used in this regimen is approximately 35% lower than standard model in Poland.
报告了对33例涂片阳性肺结核患者的治疗结果。治疗方案为:前两周每日使用异烟肼、利福平、吡嗪酰胺和链霉素;第3至8周,同样使用这四种药物,但剂量稍高,每周两次;接下来的第9至26周,异烟肼和利福平同样每周两次,这是波兰的标准治疗模式。采用上述治疗方案治疗后,所有患者痰涂片均转为阴性,且观察到影像学改善。高剂量药物耐受性良好。唯一的实验室检查异常是尿酸水平暂时升高,在治疗结束前恢复到正常水平。该治疗方案中抗结核药物的费用比波兰的标准模式低约35%。